Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001765581-20-000057
Filing Date
2020-06-03
Accepted
2020-06-03 17:04:24
Documents
2
Period of Report
2020-06-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 3  
1 PRIMARY DOCUMENT edgardoc.xml 3 1531
2 EDGAR SUPPORTING DOCUMENT poasablich.txt EX-24 3633
  Complete submission text file 0001765581-20-000057.txt   6676
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Issuer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MYOVANT SCIENCES INC. 2000 SIERRA POINT PARKWAY BRISBANE CA 94005
Business Address
Sablich Kim (Reporting) CIK: 0001758790 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33500 | Film No.: 20940806